Active substance
Results for the substance inactivated tick borne encephalitis vaccine
2 results
About this active substance
The inactivated tick-borne encephalitis (TBE) vaccine is used to prevent infections caused by the TBE virus, transmitted through the bite of infected ticks. The vaccine contains inactivated viruses, which stimulate the immune system to produce specific antibodies, providing protection against the disease.
The vaccine is administered intramuscularly, usually in three doses for primary immunization, followed by booster doses at regular intervals to maintain immunity. It is recommended for individuals living in or traveling to endemic areas, as well as those engaging in outdoor activities in high-risk regions.
Common side effects include pain at the injection site, mild fever, fatigue, and headache. In rare cases, severe allergic reactions may occur.
The inactivated TBE vaccine is an important preventive measure for reducing the risk of infection and protecting public health in affected regions.
The vaccine is administered intramuscularly, usually in three doses for primary immunization, followed by booster doses at regular intervals to maintain immunity. It is recommended for individuals living in or traveling to endemic areas, as well as those engaging in outdoor activities in high-risk regions.
Common side effects include pain at the injection site, mild fever, fatigue, and headache. In rare cases, severe allergic reactions may occur.
The inactivated TBE vaccine is an important preventive measure for reducing the risk of infection and protecting public health in affected regions.